Gynecomastia (Male Chest) | 2. Causes and risk factors

Normal hormone changes are the most common cause. Males have both estrogen and testosterone; changes in their levels or how the body responds can stimulate breast tissue growth. Newborn breast buds often come from maternal estrogen and usually fade within months. Pubertal gynecomastia affects more than half of boys and often resolves in six months to two years. In older men, declining testosterone and a changed testosterone-to-estrogen ratio may contribute. Other causes include excess weight, certain medicines, thyroid, kidney or liver disease, and anabolic steroids or other drugs. The most common cause is often idiopathic, and breast tissue should be distinguished from fat alone.

True gynecomastia is growth of glandular breast tissue, while pseudogynecomastia is enlargement from fat. A hormonal imbalance between estrogen and testosterone can stimulate breast tissue, especially during puberty, after newborn exposure to maternal estrogen, or in older age. It may also follow certain medicines, anabolic steroids, alcohol, marijuana, obesity, or conditions such as thyroid, kidney, liver disease, or testicular tumors. It can affect one or both breasts and often causes no harm. Pubertal cases often improve within one to two years, and newborn cases usually settle within weeks. The exact cause is not always found, so a clinician may need history, examination, and sometimes imaging or hormone tests.

It can occur during puberty, in newborns, or in older adults, and may be linked to some medicines, anabolic steroids, thyroid, kidney or liver conditions, or excess weight. True gynecomastia is extra glandular tissue, while pseudogynecomastia is fat buildup; a man may have both, and one or both breasts can be affected. The breast contains firm glandular tissue and softer fatty tissue, and their ratio varies between individuals. Exercise or weight loss may not reduce glandular tissue, so the cause and tissue type matter when discussing treatment. It often goes away on its own, but some cases need hormone therapy or surgery, and a doctor can assess whether imaging or blood tests are needed.

It can occur at any age, commonly during puberty, older adulthood, or the newborn period, and may affect one or both breasts. Causes include hormonal changes, heredity, obesity, certain medicines, anabolic steroids, and conditions such as thyroid, kidney, or liver disease. True gynecomastia involves glandular tissue, while pseudogynecomastia is mainly fat. It is usually benign and often harmless, though it may cause emotional discomfort or self-consciousness. Pubertal cases often resolve by around age 20 when growth is complete. Diagnosis starts with clinical examination and direct palpation; imaging or hormone tests are used only when needed, and hormone blood tests are done only when there are other symptoms of hormonal imbalance.

Estrogen stimulates breast tissue growth while testosterone inhibits it, so a relative estrogen excess or testosterone decrease can enlarge male breast tissue. This may be physiologic in newborns, puberty, or older age, and often settles on its own. Other causes include certain medicines, obesity, thyroid, kidney or liver disease, tumors, and anabolic steroids. Hormonal imbalance is common but not the only cause; some cases remain idiopathic. Evaluation starts with examination and palpation; imaging or hormone tests are used only when clinically indicated. Hormone blood tests are not routine unless other symptoms suggest imbalance. Dr. Vishal Purohit, M.Ch. plastic surgeon in Jaipur, can explain these possibilities during consultation.

Testosterone is not simply 'low' in every case. Estrogen can suppress luteinizing hormone, reducing testosterone release from the testicles, and older men may have lower testosterone with more body fat, which can raise estrogen through aromatization. Pubertal gynecomastia often settles as testosterone rises, while anabolic steroids can contribute by converting to estrogen. Testosterone replacement may help older men with low testosterone, and testosterone is listed among medical treatments, but suitability depends on cause and assessment. Hormone blood tests are usually considered only when other symptoms of hormonal imbalance are present, and an endocrinologist may be involved if onset is sudden or well after puberty is complete.

Estrogen promotes ductal epithelial growth, elongation, vascular proliferation and stromal expansion in breast tissue, whereas androgen activity inhibits mammary growth. An increase in estrogen, decrease in testosterone, or reduced androgen responsiveness can trigger glandular hypertrophy. Estrogen also suppresses luteinizing hormone, reducing testosterone release. This imbalance commonly occurs in newborns, puberty and older age; older men may have lower testosterone and more body fat, which can raise estrogen. Medications, anabolic steroids, obesity, thyroid, kidney or liver disease can contribute, and about one in four cases has no identified cause. Pubertal and newborn cases often settle naturally, while persistent or sudden changes warrant medical review, and androgen levels can vary with age, weight and medications.

Gynecomastia usually reflects an imbalance between male hormones (androgens) and estrogen. Estrogen encourages breast tissue growth, while testosterone normally limits it. Low testosterone can occur when the testes or the brain signals that control them are not working well; in some cases more testosterone is converted into estrogen. Older men may make less testosterone, and higher body fat can raise estrogen levels. When testosterone stays low for a long time, gynecomastia may not settle without treatment. In older men with low testosterone, testosterone replacement may help. Other causes include medications, obesity, liver or kidney disease, and unknown factors, so evaluation matters.

Estrogen and testosterone have opposite effects on breast tissue: estrogen encourages growth, while testosterone limits it. Estrogen excess may come from testicular or non-testicular sources, liver disease, malnutrition, or medicines with estrogen-like or anti-androgen effects. Chronic liver disease can also raise sex hormone-binding globulin, reducing free testosterone action. Gynecomastia is benign breast tissue enlargement, not fat alone; obesity can mimic it. In about one quarter of cases, no cause is found. Hormonal imbalance is the usual mechanism, but evaluation matters when symptoms are new, sudden, or accompanied by other concerns. A clinician may check for medications, liver or thyroid issues, and other conditions before deciding treatment.

Normal results mean no clear hormone cause was found, not that the breast tissue change is imaginary. Idiopathic gynecomastia is defined by normal liver, thyroid, kidney and sex hormone tests. In pubertal gynecomastia, most adolescents have normal estrogen levels. One study found idiopathic patients were older, with higher BMI and lipid values, and had higher testosterone and estradiol; FSH and LH were slightly higher but not statistically significant, with BMI, HDL and gonad stage as major associated factors. Other possible causes include medicines, anabolic steroids, excess weight, thyroid, kidney or liver disease. Gynecomastia is often harmless and may not need treatment, but persistent or bothersome changes deserve individual assessment.

ASPS lists heredity among possible causes, and MedlinePlus notes genetic variants as a rare cause. Klinefelter syndrome (XXY), the most common congenital cause of primary low testosterone, is associated with gynecomastia in up to 70% of affected individuals and carries a substantially increased male breast cancer risk; related gynecomastia is typically progressive and unlikely to resolve without intervention. Congenital causes can be physiologic, such as neonatal, pubertal or age-related changes, or pathologic; unknown causes remain frequent. It can occur at any age and may be unilateral or bilateral. Idiopathic causes remain the most frequent diagnosis in about 25% of cases. Distinguishing breast tissue from fat alone matters when assessing cause.

ASPS lists heredity among possible causes of gynecomastia, alongside hormonal changes, obesity and certain drugs. MedlinePlus notes genetic variants are a rare cause, while normal hormone changes are the most common cause in newborns, boys and men. A thorough history should include family history, including BRCA germline mutations and Klinefelter syndrome. Because causes vary, distinguishing breast tissue from fat and checking for underlying conditions matters before deciding on treatment. Hormonal changes, weight, medicines and medical conditions can all contribute, so evaluation should be individualized. Family history may guide whether further assessment is useful. No specific method or outcome is implied. Dr. Vishal Purohit can explain relevant options during consultation.

Gynecomastia is breast tissue development in males, in one or both breasts, and causes include congenital and acquired factors. In newborns, maternal estrogen can produce temporary breast tissue or breast buds; after birth, estrogen levels fall and the tissue usually resolves. Newborn breast buds often resolve within two to six months, though they can last longer in rare cases; this is usually harmless. Other causes include puberty, aging, medicines, health conditions, weight, and substances. Persistent, one-sided, hard, painful, or skin-changing breast growth needs medical evaluation rather than assuming normal newborn gynecomastia. Distinguishing breast tissue from fat alone matters when assessing the cause. It often improves without treatment. If changes persist beyond the usual timeframe, consult a clinician.

During puberty, rising hormones do not always rise in perfect balance; a temporary excess of estrogen relative to testosterone can stimulate glandular breast tissue. This is why a small, often tender lump may appear behind one or both nipples, usually gradually and often on both sides. It is common in many boys, affecting more than half of adolescents in many studies, and usually resolves within about a year as hormone levels settle. If enlargement is rapid, larger than about 4 cm, or persists beyond a year or after age 17, it may be less likely to settle and should be assessed for other causes, sometimes with closer follow-up.

Gynecomastia is overdeveloped male breast tissue, not fat alone. It most often occurs during newborn, puberty and older adulthood, but can occur at any age. Hormone imbalance between estrogen and testosterone is common; aging, obesity, medicines, anabolic steroids, thyroid, kidney or liver disease can also contribute. Pubertal cases often resolve within six months to two years; persistence beyond one year or after age 17 is less likely to resolve spontaneously. Pathologic causes are uncommon in adolescents but may need evaluation. Distinguishing breast-tissue enlargement from fat alone matters when assessing cause. Treatment may involve addressing an underlying condition or considering medicines or surgery, depending on cause and persistence. Gynecomastia does not automatically mean an operation is necessary.

Gynecomastia means enlarged male breast tissue from ductal tissue, stroma and/or fat. Physiologic gynecomastia occurs in newborns, puberty and older adults over 60; incidence rises again in men older than 65, thought to reflect declining testosterone and a changed testosterone-to-estrogen ratio. Nonphysiologic gynecomastia can occur at any age from medical conditions, medicines or substance use. NHS lists hormone changes in men over 50, overweight, certain medicines, thyroid, kidney or liver disease and anabolic steroids among causes. Hormonal changes, heredity, obesity and certain drugs can contribute, and systemic causes include adrenal, liver, pituitary, thyroid or kidney disease. So after 30, new or persistent enlargement deserves cause review rather than assuming puberty.

With age, testosterone declines while subcutaneous fat increases. Fat tissue contains aromatase, which converts androgens such as testosterone into estrogens. Sex hormone binding globulin also rises and binds androgens more tightly than estrogens, further increasing the estrogen-to-androgen ratio. This hormonal shift can stimulate male breast tissue growth, sometimes called senile gynecomastia. The incidence rises again in men older than 65 years, and senile gynecomastia is reported in 24–65% of older males. It may be more common in overweight or obese men and in men aged 50 or older. Other causes, including medicines, liver or kidney disease, thyroid problems, or tumors, should be considered when onset is sudden or accompanied by other symptoms.

True gynecomastia is glandular tissue growth, often from hormone imbalance; obesity can raise estrogen activity through aromatase in fat and is also associated with true gynecomastia. Pseudogynecomastia is fat deposition without glandular proliferation and is often linked to obesity. Obesity can also cause pseudogynecomastia, an increase in breast size from excess adipose tissue. Weight loss may reduce chest size when fat predominates, but may not fully address glandular or skin involvement. Evaluation should distinguish tissue types before deciding treatment. In adolescents, gynecomastia is often idiopathic or obesity-related, while secondary causes are rarer. Gynecomastia can occur at any age and may be associated with obesity among other causes.

True gynecomastia most often reflects an imbalance between testosterone and estrogen, and obesity is also listed among possible causes. In overweight men, fat can accumulate in the chest and mimic or add to glandular enlargement; this fat-predominant change is pseudogynecomastia. Most cases do not require treatment, though the condition may cause distress. NHS guidance notes being very overweight can cause breast tissue to grow, while also saying surgery is not suitable when large breasts are simply from being overweight. A physical examination, sometimes with ultrasound or MRI, helps separate gland from fat. Hormone testing is reserved for other symptoms of imbalance.

Obesity is associated with true gynecomastia as well as pseudogynecomastia. Gynecomastia most often reflects a hormone imbalance, not weight alone. New research suggests leptin and aromatase activity linked to obesity may increase circulating estrogens, which can stimulate breast tissue. NHS lists being overweight among possible causes. Refeeding after prolonged malnutrition can also trigger breast tissue proliferation, though that is a different mechanism. A clinical exam helps tell fat from gland, and imaging when needed. If surgery is considered, ASPS notes final results are permanent in many cases, but weight gain can affect results, so stable weight matters. Weight loss may reduce chest size when fat predominates, while glandular tissue may need different management.

Gynecomastia is enlarged male breast tissue that can occur at any age and may affect one or both sides. It may be true glandular tissue, fat-related fullness, or a mix. Weight loss can reduce fatty chest size, but it may not remove glandular tissue or redundant skin; after massive weight loss, sagging and skin redundancy can become more visible. Surgery may be considered for remaining gland or skin, while men whose large breasts are mainly from being overweight may not be suitable. Dr. Vishal Purohit can assess grade, skin quality and suitability during consultation. He uses tumescent liposuction with sharp periareolar gland excision, not VASER, laser or power-assisted methods.

Obesity-related leptin and aromatase activity may raise estrogen levels, contributing to true gynecomastia, whereas pseudogynecomastia is fat enlargement without gland growth. Refeeding after prolonged malnutrition can also trigger breast tissue growth because liver recovery lags in breaking down estrogen. For surgery, stable weight for at least six months is preferred; significant fluctuations can affect results and may lead to complications. Weight loss may reduce chest size in pseudogynecomastia, but glandular tissue may remain. Hormonal imbalance should be addressed before surgery when present. Being overweight is also recognised as a cause and may contribute to breast enlargement. Weight fluctuations alone do not always cause true gynecomastia, but they can alter chest appearance and surgical planning.

Gynecomastia is enlarged male breast tissue, most often from an imbalance between estrogen and testosterone; estrogen stimulates breast tissue growth while androgens oppose it. Hormonal disorders that may contribute include hypogonadism, Klinefelter syndrome, testicular or other tumors, and liver, thyroid or kidney disease. Medicines, anabolic steroids, obesity, malnutrition and other conditions can also play a role. The cause remains unknown in about one quarter of cases. Newborn and pubertal cases often settle without treatment. If a hormonal disorder is suspected, clinicians may consider endocrine screening and hormone levels; treating the underlying condition may reduce breast enlargement. Gynecomastia is benign breast tissue enlargement, not cancer. It can affect one or both sides.

In cirrhosis, the liver may break down estrogen less effectively, while sex hormone–binding globulin can rise and free testosterone fall, shifting the estrogen-to-testosterone ratio. Alcohol-related liver disease may add risk because ethanol can inhibit testosterone production and alcoholic drinks may contain phytoestrogens. Liver disease is only one possible cause; hormone imbalance, medicines, kidney disease, thyroid problems and obesity can also be involved. If an underlying condition is causing breast enlargement, treating that condition may help reduce it. Gynecomastia is usually benign, but new, painful or one-sided changes should be assessed by a clinician. Hormone blood tests are usually considered only when other symptoms of hormonal imbalance are present.

In chronic kidney disease, hormonal imbalance may occur because testosterone production can be suppressed and testicular damage may occur with high urea levels. Gynecomastia has been observed in 50% of patients with chronic kidney disease undergoing dialysis. Dialysis may allow previously malnourished patients to regain weight, and dialysis-associated gynecomastia may resolve spontaneously within one to two years. Kidney disease is also listed among conditions that can be associated with gynecomastia, so medical evaluation matters. If gynecomastia is caused by an underlying condition, treating that condition may help reduce breast size, although individual outcomes vary. Gynecomastia is often harmless and may not need treatment, but persistent or concerning changes should be assessed.

Gynecomastia usually reflects an imbalance between estrogen and testosterone. Testicular failure can reduce testosterone, while testicular tumors may produce estrogen or hCG and increase breast tissue growth. It is important to rule out a testicular source when estrogen excess is suspected. Other causes include medicines, obesity, thyroid, kidney or liver disease, and anabolic steroids. Many cases are harmless and may not need treatment, but new, sudden or one-sided changes deserve medical assessment. A thorough history and examination help exclude treatable causes before surgery is considered. Testicular tumors are uncommon, but rapid-onset gynecomastia should be evaluated promptly. If surgery is later appropriate, recovery varies and scars may take months to fade.

Gynecomastia usually reflects an imbalance between estrogen and testosterone. Pituitary failure or low signaling to the testes is a secondary cause, and a benign pituitary tumor called a prolactinoma is a rare cause. A large prolactin-producing tumor can press on the optic chiasm, so visual field changes matter. Medicines that raise prolactin can also be relevant. Evaluation starts with examination and palpation; imaging or hormone tests are used when symptoms suggest imbalance, and endocrine referral is considered if onset is sudden, after puberty, or accompanied by other hormonal symptoms. Hormone blood tests are used only when other symptoms of hormonal imbalance are present.

Aging can lower testosterone while body fat increases; fat tissue converts androgens to estrogens, and higher sex-hormone-binding globulin can reduce free testosterone, raising the estrogen-to-androgen ratio. Progressive testicular failure and higher luteinizing hormone may also contribute. Gynecomastia is enlarged glandular breast tissue; fat-only enlargement is pseudogynecomastia. Because many pathologic states can cause gynecomastia, physiologic gynecomastia in adults remains a diagnosis of exclusion. Testosterone replacement may help older men with low testosterone, but suitability needs individual assessment. Older men produce less testosterone and have higher body fat than younger men, which can increase estrogen levels; senile gynecomastia prevalence in older males is 24-65%.

In Klinefelter syndrome, low testicular hormone production can disturb the balance between estrogen and testosterone, leading to breast tissue growth. Gynecomastia related to Klinefelter syndrome is typically progressive and unlikely to resolve without intervention. It also carries a substantially increased risk of male breast cancer compared with the general male population, so evaluation should take that risk seriously. If surgery is ever considered, removing tissue for laboratory testing may be appropriate. The exact plan depends on your symptoms, examination, hormone tests and any needed imaging. Because of this elevated oncologic risk, careful clinical assessment and appropriate follow-up are important. Your clinician may also consider whether endocrine referral is needed based on your history.

Gynecomastia means an abnormal increase in male breast tissue, not chest fat alone. It is a benign increase in glandular tissue. The most common cause is a hormone imbalance, especially changes in estrogen and testosterone. Other causes include certain medicines, medical conditions, weight, and substances such as anabolic steroids. Emotional stress is listed among rare causes, and repetitive mechanical stress can cause one-sided symptoms. It can occur at any age. No cause is found in about 25 percent of patients. Because stress is uncommon, a new or persistent change should be assessed for hormonal, medication, or medical causes rather than assumed to be stress.

Gynecomastia is a benign increase in male breast glandular tissue, most often from an imbalance between estrogen and testosterone. Certain medicines, medical conditions, obesity, anabolic steroids and other drugs can also contribute. Emotional stress is listed only as a rare cause. Obesity may instead cause pseudogynecomastia from excess fat. Because sleep loss is not among these supported causes, persistent chest changes should be assessed for hormonal, medication or medical factors rather than assumed to be sleep-related. Hormone imbalance remains the main explanation, while sleep loss is not listed among supported causes. No cause is found in about 25 percent of cases. A clinical examination can help distinguish glandular tissue from fat. Dr. Vishal Purohit can explain options during consultation.

Malnutrition can suppress hormone production; refeeding after prolonged malnutrition may trigger breast tissue proliferation because the liver recovers more slowly and cannot fully degrade estrogens, with gynecomastia usually resolving within one to two years after a balanced diet resumes. Conditions that impair absorption, such as ulcerative colitis and cystic fibrosis, may also result in gynecomastia. Obesity is different: it can cause pseudogynecomastia from fat, and elevated weight is also associated with true gynecomastia through leptin and aromatase activity increasing circulating estrogens. Malnutrition is seen in up to 40% of renal failure patients and may contribute to gynecomastia in men with renal failure.

Gynecomastia is a benign increase in male glandular breast tissue, usually from an imbalance between testosterone and estrogen. Hormonal changes, heredity, obesity, and certain drugs are also recognized causes. Medicines, anabolic steroids, excess weight, and conditions such as thyroid, kidney or liver disease can also contribute. The soy report is an association at high intake, not proof that ordinary soy foods cause gynecomastia in everyone. Distinguishing true glandular enlargement from fat-related pseudogynecomastia matters when assessing cause and options. It can occur at any age and may affect one or both breasts. If it persists, evaluation can clarify whether observation, weight management, treating an underlying condition or surgery is appropriate.

Gynecomastia is a benign increase in male glandular breast tissue, most often from an imbalance between estrogen and testosterone. It can also be associated with certain medicines, conditions such as thyroid, kidney or liver disease, obesity, anabolic steroids, and plant oils such as lavender or tea tree oil. Obesity may instead cause pseudogynecomastia, where breast size increases from fat rather than glandular tissue. One or both breasts may be affected. Pubertal cases often improve over six months to two years, and many cases are harmless and may not need treatment. If gynecomastia makes you self-conscious or you have other health concerns, talk to your healthcare provider.

Gynecomastia means glandular breast enlargement in males, not fat alone. It is usually driven by an altered estrogen-to-androgen ratio. Known causes include puberty, aging, obesity, medicines, anabolic steroids, liver, kidney or thyroid disease, and sometimes no clear cause. Guidelines advise asking about diet, especially products with high phytoestrogen doses. A case report linked heavy soy consumption to gynecomastia, but this is not evidence for chicken or eggs. Clinical examination and direct palpation come first. Ultrasound or MRI and hormone blood tests are used only when needed. True gynecomastia is gland tissue, while pseudogynecomastia is fat; doctors review medicines and steroids; diet history may include phytoestrogen-rich foods, but chicken and eggs are not implicated.

Protein supplements have no role in increasing or decreasing gynecomastia, according to Dr. Purohit's view. Anabolic steroids can cause it, and growing chest muscle can push the gland outward, making it look more prominent. Some supplements have been linked to gynecomastia, including Tribulus terrestris in performance-enhancing products, and soy intake above 300 mg daily has been reported to cause it. Because marketed preparations vary, all supplement use should be scrutinized. Gynecomastia most often reflects testosterone-estrogen imbalance; medicines, conditions, obesity, and drug use can also contribute. Discontinuing a contributing agent often leads to regression within three months. If a product seems linked to changes, discuss it with your clinician.

Gynecomastia is enlarged male breast tissue, usually from an estrogen-testosterone imbalance; it can be glandular or fat-related pseudogynecomastia. It can occur at any age, on one or both sides, with excess localized fat, glandular tissue, or sometimes skin. Medicines, anabolic steroids, obesity, thyroid, kidney or liver disease can contribute. Hormone imbalance means estrogen effects outweigh testosterone effects in breast tissue. Distinguishing glandular enlargement from fat alone matters when assessing cause. Many cases linked to puberty improve over time, but persistent or concerning changes need medical review. It is often harmless and may not need treatment. If you notice a lump, pain, skin changes, or nipple discharge, seek prompt evaluation.

Gynecomastia is enlarged male breast tissue, usually from a testosterone-estrogen imbalance. In bodybuilders, anabolic steroids or hormones in over-the-counter supplements may stimulate glandular growth; Tribulus terrestris in performance supplements has also been linked. Because these men often have little body fat, the tissue is usually glandular and fibrotic, and it may persist after stopping the product. All supplement use should be scrutinized because marketed preparations vary. Anabolic steroids can cause gynecomastia, while growing chest muscle can push the gland outward and make it look more prominent. Liposuction alone is less effective in such cases, so direct removal of the firm gland tissue is often needed.

Exogenous testosterone can suppress your body's own testosterone production, and it may not recover quickly enough between steroid cycles, allowing estrogen effects to predominate. Anabolic steroids are also listed among medicines and substances that can cause gynecomastia. Using other drugs to try to prevent or shrink steroid-related breast enlargement has unclear benefit and safety. Anabolic steroid use carries health risks beyond gynecomastia and is illegal in many countries. Stopping use or changing medicines may help in some cases, but do not stop prescribed medicines without medical advice. Gynecomastia can occur at any age, may affect one or both breasts, and can cause emotional discomfort. If you are worried, an honest medical history helps clarify the cause.

Gynecomastia means enlarged male breast tissue. Estrogen promotes breast tissue growth, while testosterone limits it. Exogenous testosterone can suppress natural testosterone production, and it may not recover quickly enough between steroid-injecting cycles to prevent estrogen predominance. Anabolic steroid use often causes irreversible gynecomastia. In contrast, testosterone replacement can treat gynecomastia in older males with low testosterone. Medicines, obesity, thyroid, kidney or liver disease, and other conditions can also contribute. Distinguishing breast tissue enlargement from fat alone matters when assessing the cause. Many cases improve without treatment, but persistent or concerning changes need medical review. Hormone blood tests are used only when other symptoms of hormonal imbalance are present.